Total Funding
48
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1376096
Oxxon Pharmaccines Ltd., an Oxford, UK-based biotech company focused on immunotherapies.
Acquired by 
Oxford BioMedica
About the Company
Oxxon Therapeutics™ (Oxxon) is a company developing the next generation of innovative antigen-specific immunotherapies to treat patients with chronic infectious diseases and cancer.
To date, the company has built an initial pipeline through its patented Hi-8™ PrimeBoost immunotherapy platform, an approach that allows the rapid development of
products to selectively stimulate and enhance potent immune responses against disease.
The company has successfully completed phase II clinical programmes in melanoma and hepatitis B and has a third development programme underway in HIV.
In addition, the company intends to leverage its enabling platform through partnerships with companies developing therapeutic and preventative vaccine products.
